Next‐generation agents for fluorescence‐guided glioblastoma surgery
Abstract Glioblastoma is a fast‐growing and aggressive form of brain cancer. Even with maximal treatment, patients show a low median survival and are often subjected to a high recurrence incidence. The currently available treatments require multimodal management, including maximal safe surgical rese...
Saved in:
Main Authors: | Cristina Chirizzi (Author), Serena Pellegatta (Author), Alessandro Gori (Author), Jacopo Falco (Author), Emanuele Rubiu (Author), Francesco Acerbi (Author), Francesca Baldelli Bombelli (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual-targeting prodrug nanotheranostics for NIR-Ⅱ fluorescence imaging-guided photo-immunotherapy of glioblastoma
by: Fenglin Li, et al.
Published: (2022) -
Refining Glioblastoma Surgery through the Use of Intra-Operative Fluorescence Imaging Agents
by: Oluwakanyinsolami Netufo, et al.
Published: (2022) -
PGE<sub>2</sub> Is Crucial for the Generation of FAST Whole- Tumor-Antigens Loaded Dendritic Cells Suitable for Immunotherapy in Glioblastoma
by: Sara Nava, et al.
Published: (2020) -
Resection and survival data from a clinical trial of glioblastoma multiforme‐specific IRDye800‐BBN fluorescence‐guided surgery
by: Kunshan He, et al.
Published: (2021) -
The Next Generation of Scientists
Published: (2018)